Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASTX727 in PRC2 Loss Malignant Peripheral Nerve Sheath Tumor (MPNST)
NCT04872543Phase 2Recruiting
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Apr 2021
- Primary completion
- Apr 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of inqovi in malignant peripheral nerve sheath tumor (MPNST), sponsored by Memorial Sloan Kettering Cancer Center. Started Apr 2021; status: recruiting.
02
Drugs
inqovi
03
Conditions
malignant peripheral nerve sheath tumor (MPNST)
Beyond the preview
Go deeper on NCT04872543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04872543.